JPS62145017A - Antibacterial agent - Google Patents

Antibacterial agent

Info

Publication number
JPS62145017A
JPS62145017A JP28458585A JP28458585A JPS62145017A JP S62145017 A JPS62145017 A JP S62145017A JP 28458585 A JP28458585 A JP 28458585A JP 28458585 A JP28458585 A JP 28458585A JP S62145017 A JPS62145017 A JP S62145017A
Authority
JP
Japan
Prior art keywords
compound
antibacterial agent
dermatic
hydroxyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP28458585A
Other languages
Japanese (ja)
Inventor
Chikao Nishino
親生 西野
Koji Kobayashi
孝次 小林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Kasei Corp
Original Assignee
Mitsubishi Kasei Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Kasei Corp filed Critical Mitsubishi Kasei Corp
Priority to JP28458585A priority Critical patent/JPS62145017A/en
Publication of JPS62145017A publication Critical patent/JPS62145017A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE:To provide an antibacterial agent containing a specific flavone compound as an active component and exhibiting suppressing effect against indigenous dermatic bacteria. CONSTITUTION:A compound of formula (R3, R5-R8 and R2'-R5' are H or OH; R6' is H) is used as an active component of the objective antibacterial agent at an amount of 0.01-1wt% of the whole composition. The compound of formula is present in plant and is produced by extracting the plant with a proper solvent or by a synthetic means comprising the condensation of O- hydroxyacetophenone or its hydroxyl-substitution product with benzoyl chloride or its hydroxyl-substitution product and the cyclization of the resultant O- benzoxyacetophenone or corresponding hydroxyl-substitution product. It is effective against Staphylococcus epidermis which is an indigenous dermatic bacterium. The agent is useful for the prevention and remedy of dermatic diseases such as acne vulgaris (pimple). The compound is added with a base and additives and is used in the form of solution, emulsion, powder, dispersion, etc.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は抗菌剤に関する。詳しくは、皮膚常在菌に対し
て抑制効果を示す抗菌剤に関する。
DETAILED DESCRIPTION OF THE INVENTION (Industrial Field of Application) The present invention relates to an antibacterial agent. Specifically, the present invention relates to an antibacterial agent that exhibits an inhibitory effect on resident skin bacteria.

(発明の構成) 本発明者等は、植物中に含まれる各種の生理活性物質の
薬理活性について検討を行った結果、ある種のフラボン
化合物が皮膚常在菌であるスタフィロコッカス エピデ
ルミデスCSta h 1ococcus牡l」1」づ
、ATCC12228)に対し優れた抗菌力を示すこと
を確認し本発明を達成した。
(Structure of the Invention) As a result of studying the pharmacological activities of various physiologically active substances contained in plants, the present inventors found that certain flavone compounds are present in Staphylococcus epidermides CSta h 1ococcus, a resident skin bacterium. The present invention was achieved by confirming that the antibacterial activity of this antibacterial agent is excellent against the antibacterial activity of the antibacterial agent ATCC 12228).

本発明の詳細な説明するに、本発明の有効成分であるフ
ラボン(F l avo口e)化合物は例えば、Bio
−chemical  Pharmacology、3
2巻、7号、1]41〜+148頁(1983年)に記
載されている周知の物質゛であり、具体的には、フラボ
ン(化合物1)及びフラボンのヒドロキシ置換体、例え
は6.7−ジヒドロキシフラボン(化合物2) 、7.
8−ジヒドロキシフラボン(化合物3)、3ゝ、4’、
5.7−チトラヒドロキシフラボン(Luteolin
、化合物4) 、 3,5.7−ドリヒトロキシフラボ
ン(Galangin、化合物5) 、3.3p、1]
’、?−テトラヒドロキシフラボン(FiSetin、
化合物6)、3 + 3’+ 4’+ 5 + 5’+
 7− ヘキサヒドロキシフラボン(Myri−cet
in、化合物?) 、3.3’、4’、5,6.7−ヘ
キ41ヒドロキシフラボン(uuercetageti
n、化合物8) 、 2’、3゜4.5.7−ベンタヒ
トロキシフラボン(Marin、化合物9)等が使用さ
れる。
To explain the present invention in detail, the flavone (Flavo) compound which is the active ingredient of the present invention is, for example,
-chemical pharmacology, 3
Vol. 2, No. 7, 1] pp. 41-+148 (1983). -dihydroxyflavone (compound 2), 7.
8-dihydroxyflavone (compound 3), 3', 4',
5.7-thitrahydroxyflavone (Luteolin)
, compound 4), 3,5.7-dolihytroxyflavone (Galangin, compound 5), 3.3p, 1]
',? -tetrahydroxyflavone (FiSetin,
Compound 6), 3 + 3'+ 4'+ 5 + 5'+
7-Hexahydroxyflavone (Myri-cet
in, compound? ), 3.3', 4', 5,6.7-hex41 hydroxyflavone (uuercetageti
n, Compound 8), 2', 3°4.5.7-bentahydroxyflavone (Marin, Compound 9), etc. are used.

これ等の化合物は植物中に存在し、適当な溶媒により抽
出分離される。また、例えば0−ヒドロキシアセトフェ
ノン若しくはそのヒドロキシ置換体と、ペンソイルクロ
ライド若しくはそのヒドロキシ置換体とを縮合させて0
−ベンゾキシアセトフェノン又は相当するヒドロキシ置
換体とし、次いで環化することによっても得られる。
These compounds exist in plants and can be extracted and separated using appropriate solvents. For example, 0-hydroxyacetophenone or its hydroxy-substituted product may be condensed with pensoyl chloride or its hydroxy-substituted product to
-benzoxyacetophenone or the corresponding hydroxy substituted product, followed by cyclization.

上述のフラボン化合物は単離された純品である必要はな
く、これ等を含む抽出物、部分精製物等が使用され、通
常はこれ等有効成分を適当な基剤、希釈剤等と共に、全
量中0.01〜1重量%程度含有するようにして使用さ
れる。
The flavone compounds mentioned above do not need to be isolated and pure; extracts, partially purified products, etc. containing them are used, and usually these active ingredients are mixed with appropriate bases, diluents, etc., and the total amount is It is used in an amount of about 0.01 to 1% by weight.

(発明の効果) 前示[1]式で示されるフラボン化合物は、後記実施例
に示すように、皮膚常在菌であるスタフィロコッカス 
エビデルミデス (tlcce i+Iermidis
 )に対し有効な抗菌力を示す。それ故これ等化合物は
、この菌と例えはプロピオニバクテリウム アクt・ス
(Pro ionibacterium ■1蝿)とに
よる直接的刺激と、これ等の菌のリバー七作用によって
生した遊離脂肪酸の刺激作用との両者が関与していると
思われる皮膚疾患例えは尋常性座そう(にきひ、Acn
e Vulgaris )の予防、治療等に有用である
(Effect of the invention) As shown in the examples below, the flavone compound represented by the above formula [1] is a skin resident bacteria, Staphylococcus.
Iermidis (tlcce i+Iermidis)
) exhibits effective antibacterial activity. Therefore, these compounds are directly stimulated by this bacterium, for example Propionibacterium 1 fly, and stimulated by the free fatty acids produced by the liver action of these bacteria. An example of a skin disease in which both are thought to be involved is acne vulgaris.
It is useful for the prevention and treatment of E. vulgaris).

本発明の抗菌剤を使用する場合、基剤及び添加剤として
、油分、水、界面活性剤、アルコール、キレート剤、酸
化防止剤、増粘剤、色素、防腐剤等が使用され、溶渣状
、乳化状、粉末状、分散状等の形態で使用される。
When using the antibacterial agent of the present invention, oil, water, surfactants, alcohol, chelating agents, antioxidants, thickeners, pigments, preservatives, etc. are used as bases and additives. It is used in the form of emulsion, powder, dispersion, etc.

(実施例) 以下本発明を実施例について更に詳細に説明する。(Example) The present invention will be described in more detail below with reference to Examples.

[抗菌性試験] 下記に示す、寒天平板希釈法(Agar diluti
onmethod )により本物質の抗菌活性を測定し
た。
[Antibacterial test] Agar plate dilution method shown below.
The antibacterial activity of this substance was measured using the following method.

即ち、試料化合物を5%のジメチルスルホキシド水WJ
渣に懸濁させ、所定濃度とした試料溶液1]を滅菌シャ
ーレ(9cw X  2cm )に採り、これに予め1
20℃で15分間滅菌処理した感受性ディスク用培地(
栄研化学社製)91を加えて充分混合し平板固化した。
That is, the sample compound was added to 5% dimethyl sulfoxide water WJ.
Sample solution 1] suspended in the residue and adjusted to a predetermined concentration was taken into a sterile petri dish (9 cw x 2 cm), and 1
Susceptible disc culture medium sterilized at 20°C for 15 minutes (
91 (manufactured by Eiken Chemical Co., Ltd.) was added, thoroughly mixed, and solidified on a flat plate.

内径1Il1]1の白金耳を用い予め調製した試験菌を
上述の平板上に、長さ2c+n程度塗布して接種し、3
0℃で18〜20時間培養した。試験菌の発育が完全に
阻止された最小の試料溶液濃度をもって旧C1a(m1
nis+ua+ 1nhibitory concen
Lration )とした。
Using a platinum loop with an inner diameter of 1Il1], the test bacteria prepared in advance was applied and inoculated onto the above-mentioned flat plate to a length of about 2c+n.
Culture was carried out at 0°C for 18-20 hours. Old C1a (m1
nis+ua+ 1nhibitory concentration
Lration).

なお、試験菌はハートインツユジョンブイヨン培地(栄
研化学社!りを用いて30℃、18〜20゛ 時間培養
し使用直前に生理活性食塩水で100倍に希釈したもの
を用いた。
The test bacteria were cultured at 30° C. for 18 to 20 hours using heart infusion broth medium (Eiken Chemical Co., Ltd.) and diluted 100 times with physiologically active saline immediately before use.

上記の試験法により、スタフィロコッカス エビデルミ
デス(ta h  o o  us e id rm’
dS)に対する各試料化合物の旧C値を測定した結果は
、次頁の表1の通りであった。
By the above test method, Staphylococcus evidermides (tahous eid rm'
The results of measuring the old C value of each sample compound against dS) are shown in Table 1 on the next page.

表1Table 1

Claims (1)

【特許請求の範囲】[Claims] (1)下記[1]式 ▲数式、化学式、表等があります▼・・・・・・・・・
〔1〕 (式中R_3、R_5、R_6、R_7及びR_8は、
夫々水素原子又はヒドロキシル基を示し、R′_2、R
′_3、R′_4及びR′_5は夫々水素原子又はヒド
ロキシル基を示し、R′_6は水素原子を示す。) で表わされるフラボン化合物を有効成分とする皮膚常在
菌に対して抑制効果を示す抗菌剤。
(1) The following [1] formula▲There are mathematical formulas, chemical formulas, tables, etc.▼・・・・・・・・・
[1] (In the formula, R_3, R_5, R_6, R_7 and R_8 are
Each represents a hydrogen atom or a hydroxyl group, R'_2, R
'_3, R'_4 and R'_5 each represent a hydrogen atom or a hydroxyl group, and R'_6 represents a hydrogen atom. ) An antibacterial agent that exhibits an inhibitory effect on indigenous skin bacteria and contains a flavone compound as an active ingredient.
JP28458585A 1985-12-18 1985-12-18 Antibacterial agent Pending JPS62145017A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP28458585A JPS62145017A (en) 1985-12-18 1985-12-18 Antibacterial agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28458585A JPS62145017A (en) 1985-12-18 1985-12-18 Antibacterial agent

Publications (1)

Publication Number Publication Date
JPS62145017A true JPS62145017A (en) 1987-06-29

Family

ID=17680359

Family Applications (1)

Application Number Title Priority Date Filing Date
JP28458585A Pending JPS62145017A (en) 1985-12-18 1985-12-18 Antibacterial agent

Country Status (1)

Country Link
JP (1) JPS62145017A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19980072558A (en) * 1997-03-06 1998-11-05 성재갑 Flavonoid Derivatives Having Tyrosinase Activity Inhibitory Activity and a Method for Producing the Same
WO2009026166A3 (en) * 2007-08-17 2009-05-22 Herbalscience Group Llc Antiinfective flavonol compounds and methods of use thereof
JP2009236480A (en) * 2007-12-11 2009-10-15 Daikin Ind Ltd Indoor unit for air conditioner

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19980072558A (en) * 1997-03-06 1998-11-05 성재갑 Flavonoid Derivatives Having Tyrosinase Activity Inhibitory Activity and a Method for Producing the Same
WO2009026166A3 (en) * 2007-08-17 2009-05-22 Herbalscience Group Llc Antiinfective flavonol compounds and methods of use thereof
JP2009236480A (en) * 2007-12-11 2009-10-15 Daikin Ind Ltd Indoor unit for air conditioner

Similar Documents

Publication Publication Date Title
More et al. Antimicrobial activity of medicinal plants against oral microorganisms
US6248343B1 (en) Therapeutic antimicrobial compositions
US6022551A (en) Antimicrobial composition
JPH06509564A (en) antibacterial mixture
JP2693859B2 (en) Acne vulgaris skin external preparation for acne
JPH021806B2 (en)
JP2907640B2 (en) Skin external preparation for acne vulgaris
JP2848688B2 (en) Oral composition
JPS62145017A (en) Antibacterial agent
JPH09278666A (en) Antimicrobial agent and its production
Sattar et al. Evaluation of anti-fungal and anti-bacterial activity of a local plant Rhinacanthus nasutus (L.)
JPS62145016A (en) Antibacterial agent
US6607712B2 (en) Composition and methods containing an antimicrobial essential oil extended from Coleus forskohlii
JPH06336421A (en) External agent for skin
JP4666938B2 (en) Plant antibacterial composition
JP3577113B2 (en) External preparation for skin
JPH045222A (en) Crude drug extract for oral cavity and composition for oral cavity containing the same as active ingredient
CN114096229A (en) Use of dianhydrohexitols for eliminating the effects of acne, dandruff and off-flavours on cosmetic instruments
JPH05271085A (en) Agent for preventing periodontosis
JP2001064163A (en) Antimicrobial agent
ATE442836T1 (en) PRODUCTS FOR TREATING HAIR
JP2000281553A (en) Sterilizer composition
RU2203035C1 (en) Pharmaceutical composition with disinfecting, sporocidal and wound-healing properties
KR100822416B1 (en) Fragrance composition with antimicrobial effect and cosmetic composition comprising the same
JPH02215706A (en) Antimicrobial composition and cosmetic